Get started
Author

Sonal Jangalwe

Observed names: Jangalwe, Sonal, S Jangalwe, Sonal N Jangalwe
ORCID: 0000-0002-2464-4711
Observed ORCID: 0000-0002-2464-4711
OpenAlex ID: A5081336918
Humanized Mouse Models of Clinical Disease
2016 · Nicole C. Walsh, Laurie L. Kenney, et al. · Annual Review of Pathology Mechanisms of Disease · 595
Improved B cell development in humanized NOD ‐scid IL2Rγ null mice transgenically expressing human stem cell factor, granulocyte‐macrophage colony‐stimulating factor and interleukin‐3
2016 · Sonal Jangalwe, Leonard D. Shultz, et al. · Immunity Inflammation and Disease · 119
PDF
Humanized mouse models of immunological diseases and precision medicine
2019 · Leonard D. Shultz, James Keck, et al. · Mammalian Genome · 118
Human immune system development and survival of non-obese diabetic (NOD) - scid IL2r γnull (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells
2013 · L Covassin, S Jangalwe, et al. · Clinical & Experimental Immunology · 117
IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8+ T Cells Responding to Persistent LCMV Infection
2015 · Ribhu Nayar, Elizabeth Schutten, et al. · PLoS ONE · 23
PDF
Cutting Edge: Early Attrition of Memory T Cells during Inflammation and Costimulation Blockade Is Regulated Concurrently by Proapoptotic Proteins Fas and Bim
2019 · Sonal Jangalwe, Varun N Kapoor, et al. · The Journal of Immunology · 5
376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
2023 · Ribhu Nayar, Shazad A Khokhar, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
364 Non-clinical development of T-Plex component TSC-200-A0201: a natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors
2023 · Sonal Jangalwe, Badr Kiaf, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
384 Development of a target agnostic platform to assess the reactivity of T cell receptor (TCR)- engineered T cell (TCR-T) therapies to primary human tissues
2024 · Sveta Padmanabhan, Shubhangi Kamalia, et al. · Journal for ImmunoTherapy of Cancer
182 Discovery of TSC-203-A02: A PRAME-specific TCR-T cell therapy candidate for the treatment of solid tumors
2022 · Mollie Jurewicz, Elizabeth Hall, et al. · Journal for ImmunoTherapy of Cancer
PDF
Discovery of TSC-101: A First-in-Class Natural HA-2-Specific TCR to Treat Leukemia Following Hematopoietic Stem Cell Transplant Therapy
2021 · Ribhu Nayar, Mollie M Jurewicz, et al. · Blood
156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy
2020 · Ribhu Nayar, Sonal Jangalwe, et al. · Journal for ImmunoTherapy of Cancer
Regulation of Alloreactive CD8 T Cell Responses by Costimulation and Inflammation
2017 · Jangalwe, Sonal · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
PDF
A novel anti-CD40 antibody prevents activation of alloreactive T cells and prolongs skin allograft survival
2016 · Sonal N Jangalwe, Kerry Ralph, et al. · The Journal of Immunology
IRF4 regulates the ratio of T-bet to eomesodermin in CD8+ T cells responding to persistent LCMV infection (IRM14P.447)
2015 · Ribhu Nayar, Elizabeth Schutten, et al. · The Journal of Immunology
Differential regulation of alloreactive CD8 T cell responses by inflammation. (IRC8P.440)
2015 · Sonal Jangalwe, Dale Greiner, et al. · The Journal of Immunology
Role of inflammation in preventing the induction of transplantation tolerance (TRAN1P.876)
2014 · Sonal Jangalwe, Amy Cuthbert, et al. · The Journal of Immunology
Works count: 17
Citation count: 979
H-index: 5
I10-index: 5
Year
Topic
Type